Shire Seizes On Gaucher Opening With EMEA Filing For Velaglucerase
This article was originally published in The Pink Sheet Daily
Executive Summary
Given the shortage of Genzyme's Cerezyme treatment, European regulators decided to grant an accelerated review for Shire's medication.